Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012

Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013

Published:2016-06-22 Issue:1 Volume:15 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Dorkenoo Améyo M.,Yehadji Degninou,Agbo Yao M.,Layibo Yao,Agbeko Foli,Adjeloh Poukpessi,Yakpa Kossi,Sossou Efoe,Awokou Fantchè,Ringwald Pascal

Funder

World Health Organization, Headquarter, Geneva, Switzerland

Ministère de la santé , Togo

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/s12936-016-1381-8

Reference26 articles.

1. O’Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10:545–55.

2. WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015.

3. Dorkenoo MA, Barrette A, Agbo YM, Bogreau H, Kutoati S, Sodahlon YK, et al. Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005–2009. Malar J. 2012;11:338.

4. Vestergaard LS, Ringwald P. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. Am J Trop Med Hyg. 2007;77(6 Suppl):153–9.

5. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–23.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malaria;Microbiology Spectrum;2024-08-28

2. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021;Malaria Journal;2024-04-03

3. Increase of Plasmodium falciparum parasites carrying lumefantrine-tolerance molecular markers and lack of South East Asian pfk13 artemisinin-resistance mutations in samples collected from 2013 to 2016 in Côte d’Ivoire;Journal of Parasitic Diseases;2024-01-12

4. Distribution of Plasmodium falciparum K13 gene polymorphisms across transmission settings in Ghana;BMC Infectious Diseases;2023-11-16

5. A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria;Malaria Journal;2023-06-17